Iterum Therapeutics
ITRM
#9534
Rank
A$75.43 M
Marketcap
$2.18
Share price
25.23%
Change (1 day)
-10.91%
Change (1 year)

Earnings for Iterum Therapeutics (ITRM)

Earnings in 2024 (TTM): -A$33.54 Million

According to Iterum Therapeutics's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -A$57.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iterum Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -A$34.55 Million-39.41%
2023 -A$57.02 Million-13.03%
2022 -A$65.56 Million-51.03%
2021 -A$0.14 Billion135.87%
2020 -A$56.76 Million-64.48%
2019 -A$0.16 Billion33.65%
2018 -A$0.12 Billion159.97%
2017 -A$46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion 549.17%๐Ÿ‡บ๐Ÿ‡ธ USA